- After rising nearly 44% yesterday on the announcement of their new LFR technology platform, which improves accuracy and reduces the amount of DNA required for … Continue Reading
Read now- Merck (NYSE: MRK) is up in pre-market trading as the company announced that its trial for osteoporosis candidate, odanacatib, was stopped early due to robust … Continue Reading
Read nowInterviews - Abaxis (NASDAQ:ABAX) CEO Clint Severson discusses opportunities for growth and comments on the Federal Trade Commission’s (FTC) investigation into Idexx Laboratories’ (NASDAQ:IDXX) non-compete agreement with … Continue Reading
Read nowInterviews - Discussing Rigel Pharmaceutical’s (NASDAQ:RIGL) immunomodulatory Rheumatoid Arthritis (RA) treatment, CEO Jim Gower says it has the potential to replace TNF inhibitors as the standard-of-care, with … Continue Reading
Read nowInterviews - Scientists at Washington University in St. Louis, Missouri were studying two hormones – human Chorionic Gonadotropin (hCG) and Luteinizing Hormone (LH) – when they made … Continue Reading
Read now- Obagi Medical Products (OMPI) continues an upward trend this morning on rumors and further evidence of a potential takeover. Within an hour of the closing … Continue Reading
Read now- QCOR shares were off approximately 29% yesterday on a negative report from Citron Research. Analysts including Oppenheimer and Jefferies are out defending the stock this … Continue Reading
Read now